Anyang Tumor Hospital

Anyang, Henan 455001

3 studies enrolling now · 4 studies all time

What they study most

Gastroesophageal Junction Adenocarcinoma, HER2-positive Advanced Solid Tumor, Marginal Zone Lymphoma, Metastatic Gastric Adenocarcinoma, Non-Small Cell Lung Cancer (NSCLC), Relapsed/Refractory Follicular Lymphoma

Studies at this site

• A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma — Recruiting now
• A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) — Recruiting now
• A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors — Recruiting now
• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling